Studies Suggest Polygala tenuifolia extract Has the Potential to Enhance Mood and Ease Anxiety

Polygala tenuifolia extract from Linden Botanicals

Polygala tenuifolia extract from Linden Botanicals

OM Mood Support (Polygala tenuifolia extract) from Linden Botanicals

OM Mood Support (Polygala tenuifolia extract) from Linden Botanicals

Polygala tenuifolia (Yuan Zhi)

Polygala tenuifolia (Yuan Zhi)

Polygala tenuifolia (Yuan Zhi) from Linden Botanicals

Polygala tenuifolia (Yuan Zhi) Offers Many Health Benefits

Linden Botanicals - The World's Healthiest Teas and Extracts

Linden Botanicals – The World’s Healthiest Teas and Extracts

Polygala tenuifolia herbal extract may provide mood support, ease anxiety, improve sleep quality and creative thinking, and help discharge repressed emotions.

Polygala tenuifolia extract may enhance emotional stability and mood. Buddhist monks use it for meditation and focus. Some call it the Will Strengthener. Read our Polygala FAQ to learn more.”

— Michael Van der Linden, Owner of Linden Botanicals

DENVER, CO, UNITED STATES, January 19, 2021 / — Scientific studies suggest that Polygala tenuifolia herbal extract provides mood support and may ease anxiety, improve sleep quality, heighten creative thinking, help discharge repressed emotions, and enhance dreaming and manifested ideas. It may calm and relax the body by easing restlessness and anxiety. Its Chinese name, Yuan Zhi, translates to “high aspirations.”

“In Traditional Chinese Medicine terms, Polygala tenuifolia balances the qi of the heart and kidneys, thereby providing mood support and enhancing emotional stability,” says Linden Botanicals owner Michael Van der Linden. “It’s valued for its reputed ability to provide protection to the brain, and Buddhist monks use it for meditation and focus. Adherents call it the Will Strengthener. The Linden Botanicals Polygala FAQ provides a lot of information about this amazing extract.”

A Phytotherapy Research Journal study notes that Polygala tenuifolia “promotes the proliferation of neural stem cells, [which] may contribute to the therapeutic benefits of [Polygala] for the treatment of patients with insomnia, neurosis and dementia.” A study in Neurochemical Research Journal further suggests that Polygala can go beyond simply being neuroprotective and can promote neural stem cell proliferation and differentiation, pushing the plant into a special category of nootropics that support new brain cell growth.

Studies substantiate Polygala tenuifolia’s mood support potential and possible effects on mood. A Public Library of Science Journal study says Polygala “exerts rapid-onset antidepressant effects … and may be worthy of further evaluation as a safe substitute to other rapid-onset antidepressants [with] unacceptable side effects.”

Polygala may not only provide mood enhancing support but also improved memory, improved focus, and protection against cognitive ailments.

“There’s good reason to believe that a lifestyle-related approach to optimal health will benefit from support with Polygala as a mood support health supplement,” Van der Linden says. “It even has potential as an antidepressant and appears to have adaptogenic action on cortisol [the stress hormone].”

Those in search of in-depth, science-based answers to questions about Polygala tenuifolia can read Linden Botanicals’ Polygala FAQ. Linden Botanicals sells Polygala extract in its online store.

About Linden Botanicals: Linden Botanicals sells the world’s healthiest teas and extracts, including Cistus incanus, Phyllanthus niruri (Chanca Piedra), and Polygala tenuifolia (Yuan Zhi). These teas and extracts provide science-based support for mood, brain health, immune health, stress relief, energy, memory, kidney health, joint health, digestive health, inflammation, hormonal balance, and detox/cleanse. Visit to learn about the company’s teas and extracts and find hundreds of valuable health tips and resources. U.S. orders $75+ ship free.

Carolyn Daughters
Linden Botanicals
+1 3035066864
Visit us on social media:

Source: EIN Presswire

Family Room Entertainment (FMYR) Shifts Gears with Acquisition of Cannabis Operations

FMYR announces change of directions by acquiring cannabis operations

Family Room Entertainment Corp. (OTCMKTS:FMYR)

We are very excited to officially announce the launch of operations in the cannabis and hemp sector.”

— Mark Cheung

LAKE FOREST, CALIFORNIA, USA, January 19, 2021 / — Family Room Entertainment Corp. (the “Company’) makes it official and announces that it has changed directions. Executive management has focused the past two years acquiring strategic company assets and personnel to best enter a new market. Family Room Entertainment Corp. is proud to unveil our plans to redirect Family Room into the cannabis and hemp markets. The Company is also working on more new developments for 2021.

Medical and Recreational Cannabis and Hemp are dominating new market spaces in the United States. The 2019 US Farm Bill legalizing Hemp trade in the United States, and trends leading toward national legalization of Cannabis, expose a void of supply chains in blooming cannabis and hemp markets. The legal cannabis and hemp industries have shown the greatest potential for growth in current US markets.

The Company in the Summer of 2018, appointed Mark Cheung as its CEO. Mark was tasked by the board to secure assets and experts in the California cannabis industry to add to the Family Room umbrella.

Effective October 1, 2018, the Company acquired a major California Central Valley industry retailer, Sweet Leaf Hydroponics, through the Company’s acquisition of Safestarr Inc.

Sweet Leaf Hydroponics has been supplying cannabis and hemp industry supplies, “picks and shovels”, installation and consultation services to cannabis cultivators, hemp cultivators, and extractors in the Central Valley of Northern California for the past 10 years. Such a retail hydroponics location grants the Company direct access to the cannabis industry supply chain (“picks and shovels”) and longstanding legacy cultivators.

“We are very excited to officially announce the launch of operations in the cannabis and hemp sector,” said Mark Cheung, the Company’s CEO. “We believe that positioning the Company in the very relevant cannabis sector will immediately enhance growth potentials and provide value to our company.”

About Family Room Entertainment Corp.
With its headquarter office located in Lake Forest, California, and founded in 1969 originally as Cobb Resources, Family Room Entertainment Corp. (the “Company”) has focused its business operations in the cannabis sector with its acquisition of Safestarr Inc., a California corporation, which operates under the trade name of Sweet Leaf Hydroponics. Through the acquired operations, the Company markets and sells equipment for cultivators, extraction products, topsoil, and other various “picks and shovels” equipment necessary for cannabis and hemp operations. The Safestarr subsidiary has an active social media presence at its own website ( and on Facebook ( and Instagram (@sweet_leaf_hydro).

Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

Family Room Entertainment Corp.

Info Office
Family Room Entertainment Corp.

Source: EIN Presswire

Aarna Networks Launches New Open Source Software Product to Combat Increased 5G Network and Edge App Management Stress

Aarna Networks Logo

Aarna Networks Multi Cluster Orchestration Platform Logo

SAN JOSE, CA, USA, January 19, 2021 / — Aarna Networks, a leading 5G and edge computing company, announced a new software product, Aarna Networks Multi Cluster Orchestration Platform 2.0 (AMCOP), that offers zero touch 5G solutions for B2B use cases. The new product performs orchestration, lifecycle management, and real-time policy driven control loop automation and features a brand new end-to-end 5G network slicing manager.

With the 5G edge computing for B2B expected to reach a $10.8 billion economy by 2030 (ABI Research), AMCOP enters the market as a solution for large enterprises who do not want to dedicate a large IT department, but are looking for reliable, low latency wireless connectivity and industry specific edge computing applications.

“5G and edge computing are key developments in the telecom industry right now. These are expected to open up new revenue opportunities for service providers, particularly in the enterprise market,” said James Crawshaw, Principal Analyst, Omdia. “The networks that support these new technologies are increasingly software driven. Tuning the software stack from the underlying cloud infrastructure to the applications that run on top is a critical industry challenge. As these problems are solved, attention will turn to the management solutions that enable automation. Operators should be proactive in looking for robust management tools now, to be ready to rapidly scale their new services as demand accelerates.”

“Enterprises are looking for a zero touch 5G and edge computing solution with a large choice of applications and connectivity to public networks," said Amar Kapadia, CEO and co-founder of Aarna Networks. “As 5G and edge industries continue to grow, the AMCOP product fills this gap by creating a platform that is vendor neutral, cloud native, and with full 5G support. The addition of an end-to-end network slicing manager will help unlock the true promise of 5G.”

By addressing enterprise use cases such as Industry 4.0, Aarna Networks is able to use a subset of Open Network Automation Platform (ONAP) projects — Edge Multi Cluster Orchestrator (EMCO) and Controller Design Studio (CDS) — which allows for intent-based orchestration of 5G network services and edge computing applications as well as comprehensive lifecycle management.

The new AMCOP product includes several key differentiators from other platforms including:
* Vendor Agnostic
* Fully Cloud Native
* 100% Open Source
* Comprehensive 5G support
* Standards compliant
* Lightweight and easy-to-use

In addition to initial trials, AMCOP has two active community 5G Proofs of Concept (PoCs), three paid 5G PoCs and was recognized as a LF Open Network & Edge Summit keynote speaker and NSIN Navy/Marine Corps 5G competition participant. Aarna Networks recently joined the Open Networking Foundation to participate in the SD-RAN/Near Real Time RIC project and was also recognized as one of CRN’s 10 Coolest Edge Computing Startups of 2020.

For more information about AMCOP 2.0 and a free trial, please visit

About Aarna Networks

Aarna Networks is an open source software company that enables orchestration, management, and automation of 5G networks and edge computing applications. 5G and Edge are a once in a generation disruption that will fundamentally change how we work and live, and Aarna Networks is well positioned to take advantage of this trend. The company uses the Linux Foundation open source projects for its products and is based in San Jose, CA and Bengaluru, India. Please visit us at or follow us on Twitter at @aarnanetworks.

Martina Corona
Matter Communications o/b/o Aarna Networks
+1 617-391-9898
email us here
Visit us on social media:

Source: EIN Presswire

State Responds with Behavioral Restraint Use Reforms After 16-yr-old’s Death

State Responds with Behavioral Restraint Use Reforms After 16-yr-olds Death

CCHR says Michigan paves the way to a nationwide need for a ban on restraints in psychiatric youth facilities following African American teen’s violent death from a restraint used for unruly behavior: throwing a sandwich on the floor

CCHR says Michigan paves the way to nationwide need for ban on restraints in psychiatric youth facilities following African American teen’s death from restraint

LOS ANGELES, CALIFORNIA, UNITED STATES, January 19, 2021 / — The state of Michigan announced it is working to end the use of restraints in the child welfare system. This is in response to the May 2020 restraint death of 16-year-old Cornelius Frederick at the now closed Lakeside Academy owned by Sequel Youth & Family Services. In June, the restraint was ruled a wrongful death and several employees were charged with manslaughter.[1] Mental health industry watchdog, Citizens Commission on Human Rights International, which made submissions to legislators in Michigan and across the country about restraint abuse, sees Michigan as paving the way to protect children, but wants their plans extended to a complete ban on physical and chemical restraints for behavioral control. CCHR also acknowledged Michigan for pursuing a criminal investigation into a restraint death, which it said should be the level of accountability nationwide when there is a restraint death in psychiatric-behavioral facilities.

CCHR’s parents’ information website FightForKids established a section warning about restraints following Cornelius’s death. The African American teen went into cardiac arrest after yelling, “I can’t breathe!” A witness said, “[T]his kid threw a sandwich. He was being unruly and they couldn’t control him. So, four guys…the size of rugby players tackled him.”[2]

According to one attorney assisting a family whose son died in a behavioral facility, the company that owns it “must be held accountable” for the “countless other children who were abused under their care.”[3]

“No one should be dying in a behavioral hospital. Until there is a ban on violent restraint use, criminal protections need to be in place. This also includes financial penalties against facilities found to abuse children and youths with restraints and hospital closures for flagrant violations,” said Jan Eastgate, international president of CCHR.

In September 2020, a steering committee led by Michigan’s Children’s Services Agency announced it would also investigate foster care and juvenile justice placement practices in the state. Hundreds of youths, including those in foster care, are sent by various states to psychiatric hospitals owned by the for-profit behavioral industry. In December, California announced it would no longer send children interstate to such facilities. Several other states have also implemented this in light of atrocities reported committed against children and teenagers.[4]

An online petition that the National Juvenile Justice Network started in the wake of the Cornelius’s death, calls for a closure of a for-profit psychiatric hospital chain and has almost 330,000 signatures to date.[5] CCHR encourages more people to support this.

Among Michigan’s proposed changes would be eliminating restraints “unless absolutely necessary” — that is, during emergencies or life-saving intervention. The reforms would mean that restraints could not be used as an intervention to control behavior or because a youth refuses to follow the rules.[6] CCHR wants to see a total ban.

CCHR believes that keeping legislative language such as restraints being necessary for a “life-saving intervention,” opens the door to misinterpretation and doesn’t close the door on putting youths and others at risk of such life-threatening interventions. It’s submission to legislators also calls for stronger penalties against facilities using abusive restraints.

The FightForKids site documents at least 32 adverse incidents of child and youth residents in one behavioral hospital chain alone, including 18 involving seclusion rooms or restraints use in children as young as six, three deaths and at least six suicides that may have been prevented.[7] Another page references more than 60 cases of abuse and warns: “Parents are often misled about a child’s troubled behavior and can be coerced into believing or otherwise convinced that putting the child into a psychiatric or behavioral facility is the right thing to do.” The advice “neglects to mention the potential harm the child or teen can be subjected to. Whether through punitive actions such as solitary confinement and seclusion rooms or torturous treatments, including debilitating drugs, behavioral modification or electric shock and chemical or physical restraints, parents should know of the risks to their child. Too many have found out too late.”[8]

Attorney Tommy James, whose client, a teenage patient that was living at a for-profit behavioral facility in Alabama, alleged the boy suffered “multiple traumas to his head causing concussions, lacerations that required stitches, hematomas [blood clots] and other injuries.” James warned of “systemic violence” in such facilities throughout the country. “The level of abuse is staggering and very disturbing. No informed parent would ever allow their child to spend even one hour” in the hospital chain’s facilities that he named. “It is disgusting when our most vulnerable children are placed in these facilities and then treated like animals,” James said.[9]

CCHR said it will to continue to document and expose abuses in the youth behavioral industry. Parents or family members can report an abuse here.

Read the full article here.

CCHR is responsible for more than 180 laws that protect patients from damaging psychiatric practices. DONATE to support its work

[1] Lynsey Mukomel, “Committee eyes 2022 for restraint reform at state youth homes,” Wood TV, 14 Jan 2021,
[3] Chelsea Retherford, “Lawsuit claims abuse at Courtland Sequel youth facility,” The Moulton Advertiser, 7 Jan 2021,
[4] Op. cit., Lynsey Mukomel, Wood TV
[6] Op. cit., Lynsey Mukomel, Wood TV
[9] Op. cit., Chelsea Retherford, The Moulton Advertiser

Amber Rauscher
Citizens Commission on Human Rights
+1 323-467-4242
email us here
Visit us on social media:

Source: EIN Presswire

California US Navy Veterans Mesothelioma Advocate Urges the Family of a Navy Veteran with Mesothelioma in California to Call Attorney Erik Karst of Karst von Oiste For a No-Obligation Consultation About Compensation

"If you are a Navy Veteran with recently diagnosed mesothelioma or their family and you have questions about mesothelioma compensation- call attorney Erik Karst of Karst von Oiste at 800-714-0303.”

— California US Navy Veterans Mesothelioma Advocate

SAN DIEGO, CALIFORNIA , USA, January 19, 2021 / — The California US Navy Veterans Mesothelioma Advocate is urging the wife or adult son-daughter of a Navy Veteran with recently diagnosed mesothelioma in California to not play the lawyer roulette with 'free' generic booklets, kits, guides, or nonsense such as mesothelioma calculators or three minute compensation tests. These are just few law firm tricks they use to identify people with mesothelioma. If a Navy Veteran with mesothelioma in California or their family would call attorney Erik Karst of the law firm of Karst von Oiste at 800-714-0303 he will be able to answer your questions about mesothelioma compensation-and he should be able to give an idea of what the person's compensation claim might be worth. Erik Karst is one of the nation's leading mesothelioma attorneys.

The Advocate says, "Because of the Coronavirus, the lock downs and upheaval in California in the last twelve months we know for a fact that some Navy Veterans and or people with mesothelioma in California have avoided the compensation process. 2020 will probably go down as the worst year for mesothelioma compensation in two decades because we think frequently people who had mesothelioma were misdiagnosed with the Coronavirus. If you are a Navy Veteran with recently diagnosed mesothelioma or their family and you have questions about mesothelioma compensation-please call attorney Erik Karst of Karst von Oiste at 800-714-0303. We think you will be glad you did. Mesothelioma compensation for a Navy Veteran can frequently exceed a million dollars."

The California US Navy Veterans Mesothelioma Advocates services are available to US Navy Veteran with mesothelioma in Los Angeles, San Pedro, San Diego, San Jose, San Francisco, Fresno, Irvine, Oakland, Long Beach, Anaheim, Bakersfield, Riverside, Sacramento, Stockton or anywhere in California. https://California.USNavyMesothelioma.Com

For the best possible mesothelioma treatment options in California the California US Navy Veterans Mesothelioma Advocate strongly recommends the following three heath care facilities with the offer to help a diagnosed victim, or their family get to the right physicians at each hospital.

*UCLA Medical Center Los Angeles, California: https://cancer.
* Stanford Cancer Institute:
* University of California San Francisco, San Francisco, California:

About one third of all US citizens diagnosed with mesothelioma each year are Veterans of the US Navy. Before a Navy Veteran with mesothelioma or their family retain the services of a lawyer or law firm, they are urged to call the US Navy Veterans Mesothelioma Advocate anytime at 800-714-0303. https://USNavyMesothelioma.Com

The states with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon.

However, based on the calls the US Navy Veterans Mesothelioma advocate receives a US Navy Veteran diagnosed with mesothelioma could live in any state including New York, Florida, California, Texas, New Hampshire, Vermont, Iowa, Indiana, Missouri, Kentucky, Tennessee, North Carolina, Georgia, Alabama, Mississippi, Oklahoma, Arkansas, Nebraska, North Dakota, Montana, Wyoming, Colorado, Nevada, New Mexico, Utah, Arizona, Idaho, or Alaska.

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer:

Michael Thomas
California US Navy Veterans Mesothelioma Advocate
+1 800-714-0303
email us here

Source: EIN Presswire

Pain Care Labs Receives 2020 Tibbetts Award for Innovation

Amy Baxter MD

Dr. Amy Baxter, Medical Doctor and Pain Researcher

The industry leader in drug-free pain relief joins a select group of past awardees, including Qualcomm, 23andMe, Symantec, and Broadcom.

Pain Care Labs innovations have led to a new category of pain relief, which has led to extensive independent, unfunded research supporting their technology.”

— Julie Collins, Former Director, SBIR GA

ATLANTA, GA, UNITED STATES, January 19, 2021 / — Pain Care Labs, the industry leader in noninvasive, drug-free pain relief solutions, announced its selection as a 2020 Tibbetts Award winner. The award recognizes the substantial economic and social benefits the company’s pain-relieving medical devices have contributed to our nation by leveraging funding from National Institutes of Health (NIH) Small Business Innovation Research (SBIR) programs.

After initial prototyping in the scientist-founder’s basement, Pain Care Labs has worked hand-in-glove with NIH research institutes. “In 2009, the National Institute of Child Health and Human Development believed in a small, all-woman business, and cared enough about vaccination pain to fund a pediatrician’s theory,” recalls Amy Baxter M.D., pediatric emergency physician and CEO of Pain Care Labs. “Our program officer was patient, passionate, and elevated the level of our science. Since that time, various program officers in the NIA, NIDA, NINDS, and other SBIR liaisons have graciously given their time and acumen to expand the business and science scope of our company.”

Pain Care Labs’ mission – to eliminate unnecessary pain – exhibits the kind of public health benefit and company investment that the SBIR program was designed to support. “As a WBENC-certified company, they have practiced inclusion and diversity,” observes Julie Collins, Former Director, SBIR GA, Innovation Coach, and NSF I-Corp Faculty. “Furthermore, their innovations have led to a new category of pain relief, which has led to extensive independent, unfunded research supporting their technology.”

Input from The National Institute on Drug Abuse has enabled Pain Care Labs to look beyond the science to the company's real potential. Dr. Baxter reflects, “SBIR funding has allowed us to expand our indications for use from vaccination and needle pain control to broader drug-free musculoskeletal pain relief.” The NIH approach links the science to the sales, facilitating translation into life-saving technologies. With federal funding provided by the NIH, Pain Care Labs is now developing and investigating a low back pain device to reduce opioid initiation or dependence.

The urgency of vaccination to address the COVID-19 pandemic amplifies Pain Care Labs important work in reducing needle pain and fear. As Renee C.B. Manworren, PhD, APRN, notes, “As we continue to face a pandemic health crisis, I am confident their first product, Buzzy®, will help accelerate worldwide vaccination against this deadly virus.”

About the Tibbetts Awards
The Tibbetts Awards are presented to companies that promote the mission and goals of the SBIR program, which include stimulating technological innovation and increasing commercialization of federal research. The Awards are named after its founder Roland Tibbetts, an active champion of the SBIR cause. He piloted the program and then served as the SBIR Program Manager at National Science Foundation from 1976-1996.

Pain Care Labs is the industry leader in noninvasive pain relief solutions. Buzzy® has been used to block pain for over 37 million needle procedures. VibraCool® is an FDA registered 510(k) cleared device to treat myofascial pain caused by trigger points, restricted motion, and muscle tension. Established in 2006 by emergency physician and pain researcher Amy Baxter M.D., the Company is dedicated to effective, reusable, and affordable solutions for pain. The Company’s award-winning solutions are based on patented Oscillice® M-Stim® , a mechanical stimulation/thermal neuromodulation platform. Pain Care Labs was named "Industry Leader for Localized Pain Relief" by Frost & Sullivan, a leading market research firm. For more information, including a list of published studies, please visit

Leisha Richardson
+1 512-633-2387
Visit us on social media:

Source: EIN Presswire

CLS Holdings USA, Inc. Reports Financial and Operational Results for December 2020

CLS Holdings USA, Inc. (CLSH) today announced the financial and operational results for its Nevada wholly owned subsidiaries for the month of December 2020

CLS Holdings USA, Inc. (OTCQB:CLSH)

As an essential business, we felt it was our responsibility to keep cannabis accessible. We’re proud to have served the community clean products in a safe environment all month long.”

— Andrew Glashow

LAS VEGAS, NV, UNITED STATES, January 19, 2021 / — CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, today announced the financial and operational results for its Nevada wholly owned subsidiaries for the month of December 2020 with net revenues of $1.49M and Gross Margin of 48.3%. The Company achieved a record increase in year-over-year revenue at its branded wholesale division, while retail sales continued to maintain steady growth. Given present economic conditions in Nevada, both divisions also offered significant promotional pricing on wholesale and retail menus in an effort to effectively serve their communities with affordable products.

CLS Nevada December 2020 Financial and Operational Highlights

-December 2020 total net revenue increased by 50.2% over December 2019.
-Retail division, Oasis Cannabis Dispensary, achieved a 50.7% increase in the average ticket total, from $36.04 in December 2019 to $54.30 in December 2020. This contributed to a year-over-year monthly revenue increase of 28.6%.
-CLS wholesale division, City Trees, saw a year-over-year increase in monthly revenue of 174%, driven by increasing market penetration and strategic partnership opportunities.
-Oasis Cannabis offered significant promotional pricing on flower products in the month of December in a coordinated initiative to provide accessible products to an economically challenged population in Las Vegas.

CLS subsidiaries achieved a revenue increase of 50.2% in December 2020 compared to December 2019, and an 89.5% increase over December 2018. The Company experienced a 2% decline in gross margin year-over-year as a result of significant promotions on both its wholesale and retail offerings. At its retail division, Oasis Cannabis, a coordinated campaign to provide flower products at lower margins, dubbed ‘Flower to the People’, was initiated in an effort to ensure access to products for the economically challenged community of Las Vegas. Despite these challenges, this division experienced its highest New Year’s Eve sales total in company history, recording a single day net revenue of $60,485.

“Nevada took a bigger economic hit than nearly any other state in the country in 2020,” noted Company President and COO Andrew Glashow. “We found ourselves in a fortunate position at the end of the year that allowed us to provide significant discounts to medical patients and recreational consumers alike. As an essential business, we felt it was our responsibility to keep cannabis accessible. We’re proud to have served the community clean products in a safe environment all month long.”

At the Company’s manufacturing subsidiary, City Trees, research and development on a new range of distillate products was finalized in December 2020. The new range of products is anticipated to be available in early February 2021. This division also experienced a 174% increase in year-over-year revenue, achieving a significant sales milestone driven in part by the continued success of its collaboration concentrate product with State Flower, which initially sold out at Oasis Cannabis in one week. Further, the brand’s market penetration has continued to increase since its relaunch in September 2020, with products now available in nearly 80% of dispensaries across Nevada. As new products are introduced to its menu and brand awareness continues to increase, the Company anticipates significant growth of this division in 2021.

About CLS Holdings USA, Inc.

CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
Twitter: @CLSHoldingsUSA

Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named "Best Dispensary for Pot Pros" by Desert Companion Magazine. In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products.

Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees products are available in numerous dispensaries throughout the state of Nevada.

Forward Looking Statements

This press release contains certain ''forward-looking information'' within the meaning of applicable Canadian securities legislation and ''forward-looking statements'' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the ''forward-looking statements''). These statements relate to, among other things, the impact of the COVID-19 virus on our business, the results of our initiatives to retain our employees and strengthen our relationships with our customers and community during the pandemic, the effect of our initiatives to expand market share and achieve growth during and following the pandemic, results of operations and financial performance, anticipated future events, and the effectiveness of our business practices during the pandemic. The continued spread of COVID-19 could have, and in some cases already has had, an adverse impact on our business, operations and financial results, including through disruptions in our cultivation and processing activities, supply chains and sales channels, and retail dispensary operations as well as a deterioration of general economic conditions including a possible national or global recession. Due to the speed with which the COVID-19 situation is developing and the uncertainty of its magnitude, outcome and duration, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be material. In some cases, you can identify forward looking statements by terminology such as ''may,'' ''might,'' ''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,'' ''goals,'' ''projects,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at for additional details.

Contact Information:

Chairman and CEO
Jeff Binder

President and COO
Andrew Glashow


Investor Relations:

Source: CLS Holdings USA, Inc.

Andrew Glashow
CLS Holdings USA, Inc.
+1 888-438-9132
email us here
Visit us on social media:

Source: EIN Presswire

ID R&D Addresses Bias in Facial Liveness With Latest Release

ID R&D Logo

Improving speed and increasing accuracy for all types of users and across various devices is critical to successfully using face for identity verification and authentication.”

— Alexey Khitrov, President, ID R&D

NEW YORK, NY, UNITED STATES, January 19, 2021 / — ID R&D, the award-winning biometrics and liveness technology provider, announced that the latest release of its passive facial liveness, IDLive Face 1.18, features algorithms that reduce AI bias across demographic groups. Inclusive product development is a top priority for ID R&D and a major focus of this release is closing accuracy gaps between ages, genders, and ethnicities.

As IDLive Face continues to experience rapid adoption by customers and partners across a growing number of countries, tackling the issue of AI bias emerged as a leading initiative. Addressing this industry-wide challenge includes investing in unbiased data collection and classification. A new machine learning pipeline in IDLive Face 1.18 further enables this initiative with improved model training for higher accuracy.

The number of IDLive Face customers grew exponentially in 2020 and now the product conducts millions of passive liveness checks monthly, across 38 countries. This growth speaks directly to market demand for ID R&D’s next generation, single image passive liveness detection solution. The unique approach uses the same selfie image that is used for facial matching, which not only makes the process imperceptible to users, but also invisible to fraudsters.

As liveness detection becomes commonplace for identity verification, particularly in the financial sector, it is critical that products are built on inclusive data sets to prevent discrimination.

“IDLive Face is a breakthrough product in that it provides proven accuracy in even the most demanding, regulated financial environments with use cases such as onboarding,” said Alexey Khitrov, President at ID R&D. “However, unlike alternative liveness products we have had a relentless focus on enabling a zero-friction user experience. Improving speed and increasing accuracy, including both false accepts and false rejects, for all types of users and across various devices is critical to successfully using face for identity verification and authentication.”

IDLive Face is the only single image passive facial liveness detection product to achieve iBeta Level 2 Presentation Attack Detection compliance. Learn more about IDLive Face or contact us for a demo.

Kim Martin
+1 4079283320
email us here
Visit us on social media:

IDLive Face Passive Facial Liveness Detection Demo

Source: EIN Presswire

Telegenetics in 2021: What to Expect

what is telegenetics

Telegenetics 2021

USA, January 19, 2021 / — Telehealth

The last few years have been exciting and fast-moving ones in the field of telegenetics and telemedicine. We have seen more and more telegenetics platforms coming to the market and also the development of some exciting AI-based platforms for genetic analysis and diagnosis.

What can we expect from the field of telegenetics in 2021?

A push for greater accessibility

Telegenetics is increasingly well known amongst genetic counselors and geneticists, and at the same time amongst increasing numbers of family physicians. This means that the use of telegenetics platforms is usually initiated by a clinician or doctor.

However, what we are going to see in 2021 is a greater push for accessibility, which allows patients and their families to access telegenetics platforms and diagnostic tools directly. This means patients with concerns and or symptoms of a rare disease can initiate their own genetic analysis. Let’s take the example of the FDNA telehealth platform. This analysis tool allows patients to schedule an online meeting with a genetic expert and allows them to directly upload a photo for facial screening, which will then generate their genetic analysis report.

This, of course, does not mean that we will see the replacement of genetic counselors and geneticists. Their roles will be as important as ever before, if not more so. In fact, this increased accessibility will mean a greater ability to be able to better connect genetic counselors and geneticists with patients directly and remotely, in the process removing obstacles to appointments, and at the same time reducing wait times for consultations.

A drive for comprehensive care

This means that telegenetics will develop, not just to provide a quicker and more accurate diagnosis, but also to provide a more complete 360 view of patients and their care. Using advanced AI technologies to generate genetic reports is an important part of telegenetics moving into 2021, but equally important are platforms that also connect patients with the necessary genetic experts. This is crucial to reach a full and comprehensive diagnosis, while also receiving essential support and assistance with the long-term management of a rare disease.

A greater emphasis on results for the patient, in terms of a diagnosis, involves combining telegenetic technology with the genetic and medical experts who can help patients manage their rare condition most effectively. Solutions that support patients throughout the entirety of their rare disease diagnosis is the future of telegenetics as it strives to deliver better patient care.

FDNA Telehealth’s approach to telegenetics doesn't just involve advanced screening technology. It also includes a network of genetic counselors and geneticists who complement the telegenetics platform.

A clearer path to affordability

Telegenetics in 2021 is set to become much more affordable. This means making it accessible to as many people as possible, with costs coming down and greater coverage by insurance companies. It also means enabling patients more direct access to telegenetics solutions.

A demand for greater accuracy

Accuracy is the watchword for telegenetics for 2021. It won’t just be about faster analysis but will mean much more accurate diagnosis too. There is a real need in the rare disease field to reduce the number of patients misdiagnosed. Research into misdiagnosis and Ehlers Danos, for example, shows that up to 56% of patients with the condition experienced at least one misdiagnosis before receiving a correct one. The only way to do this is with more precise and advanced technology.

FDNA’s platform has already analyzed over 250,000 rare patients and started them on their journey to a much more accurate diagnosis.

This drive for greater accuracy should be at the center of telegenetics in 2021 and beyond.

A real reduction in diagnosis times

The aim of telegenetics in 2021 will definitely be to reduce diagnosis times. Most rare disease patients currently wait, on average, up to 5 years for a correct diagnosis. In the meantime, this means their condition is not managed properly.

When it comes to genetic syndromes, improving patient care means delivering faster diagnosis for patients who so desperately need to be connected to the genetic experts that can provide the answers and support they need.

Continued advancements in AI technologies

Telegenetics in 2021 will see the development and improvement of the technologies driving telegenetics, especially in the field of genetic analysis and diagnosis. From facial screening technology to more advanced online telehealth platforms connecting patients to genetic experts, 2021 is going to be another fast-moving year when it comes to telegenetics technologies.

Telegenetics developed out of a need to make key genetic services more accessible to the patients and families who need these services most. In 2021, we expect to see telegenetics services reaching more patients and bringing more people closer to an accurate diagnosis. This, in turn, will mean a reduction in diagnostic journey times and ensure rare disease patients get the right information, support, care, and treatment for their condition.

Ido Rabiner
FDNA Telehealth
+1 877-327-0735
email us here

Source: EIN Presswire


World's First LGBTQ+ Meditation Courses

World’s First LGBTQ+ Meditation Courses

LGBTQ+ Meditation Courses - crafted by the LGBTQ+ Community

LGBTQ+ Meditation Courses – crafted by the LGBTQ+ Community

FISU Meditation Academy

FISU Meditation Academy

We have crafted the world's first LGBTQ+ Meditation Course beginning on Sunday, 31st January 2021 at 2 PM GMT / 9 AM EST.


We have crafted the world's first LGBTQ+ Meditation Course beginning on Sunday, 31st January 2021 at 2 PM GMT / 9 AM EST.

This 12 week course is built on our LGBTQ+ community meditators' profound and life changing experiences. Some of them are now teachers on this project to help spread the profound and life-transforming benefits of meditation to the LGBTQ+ community.

A perfect lockdown antidote!

There are many single meditation lessons and videos around the web for the community. Still, none are dedicated to taking you in a personal journey of self-discovery and strengthening over 12 weeks led by an LGBTQ+ instructor.

Ten live instructor-led sessions are delivered through our innovative course player integrated with Zoom, plus 45 self-paced study lessons via videos, audios and eBooks. The self-paced study lessons follow the course's path and deliver content relevant to the learner's experiences at this time.

Online Course Details and schedule:

Here are some of the many course benefits (an expanded version is on the site here:
• Coming Out – Gain strength to make it a celebration of your identity
• Self Acceptance & Loving Yourself
• Calm, Relaxation & Peace of Mind – Stop Mind Chatter
• Improve Mental Health Well-Being especially through lockdown
• Overcoming Depression – Meditation is more effective than medication
• Dealing with and accepting those who are homophobic or transphobic and Bullying
• How to deal with negative people and their opinions
• Cultivate Compassion & Forgiveness
• Be who you want to be – Gender does not define you
• Greater Self-Esteem and Confidence
• Sharpen Concentration and accelerate Cognition
• Scene Influences – easier to steer away from "scene" influences
• How to avoid Addictions, Promiscuity, and Dependencies

All these subjects are covered within the course plus many others.

Testimonials from the LGBTQ+ Community are here: (scroll down to testimonial area).

Our Great Value Course Pricing:
The entire 12-week course cost is a reasonable GB £199/Euro €230/USD $260 – with concessions for unemployed.

Course Sessions take place on Sundays at 2 PM GMT / 9 AM EST

75 Minute Free Introductory Talks (obligatory to attend before enrolling) are regularly scheduled.

Languages: Future Courses will be taught in English, Spanish or Greek.

FISU Meditation is a non-profit organisation and registered educational charity that teaches the art of Meditation and Spiritual Unfoldment. UK Charity No:

FISU does not have any employees worldwide, and it's teachers dedicate their time to help others as meditation has changed their lives and they want to help others change theirs.

FISU Meditation is lead by Guru Rajesh Ananda.
For more details, please contact:

FISU Meditation HQ, Marlborough Road, London, E4 9AL
Phone: Guru Rajesh Ananda Mobile: +447793 562103
Academy Online:
Main Website:
Philosophy Life-Skills Website:
Twitter: @rajeshananda
Platform: FISU's global operations run on the platform, where it was the first meditation school to adopt the platform. The FISU Meditation Academy is integrated with Salesforce.

Rajesh Ananda
FISU Meditation
+44 7793 562103
email us here
Visit us on social media:

Source: EIN Presswire